• The UK is to offer alternatives to the AstraZeneca vaccine to under-30s over reports of blood clots.
  • Officials say the “suspected” side effect is very rare, and vaccine benefits still outweigh risks.
  • But they said the decision was made as young people face more risk of clots and less from COVID-19.
  • The chart above, made by the UK Medicines and Healthcare products Regulatory Agency, shows this balance of risks.
  • See more stories on Insider’s business page.

Get the latest coronavirus business & economic impact analysis from Business Insider Intelligence on how COVID-19 is affecting industries.

Source: Read Full Article